These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Expansion of natural killer cell receptor (CD94/NKG2A)-expressing cytolytic CD8 T cells and CD4+CD25+ regulatory T cells from the same cord blood unit. Tanaka J, Sugita J, Kato N, Toubai T, Ibata M, Shono Y, Ota S, Kondo T, Kobayashi T, Kobayashi M, Asaka M, Imamura M. Exp Hematol; 2007 Oct; 35(10):1562-6. PubMed ID: 17681668 [Abstract] [Full Text] [Related]
4. Implication for the CD94/NKG2A-Qa-1 system in the generation and function of ocular-induced splenic CD8+ regulatory T cells. Chattopadhyay S, O'Rourke J, Cone RE. Int Immunol; 2008 Apr; 20(4):509-16. PubMed ID: 18359787 [Abstract] [Full Text] [Related]
6. Altered CD94/NKG2A and perforin expression reduce the cytotoxic activity in malignant pleural effusions. Pace E, Di Sano C, Ferraro M, Tipa A, Olivieri D, Spatafora M, Santagata R, Bellia V, Gjomarkaj M. Eur J Cancer; 2011 Jan; 47(2):296-304. PubMed ID: 20932742 [Abstract] [Full Text] [Related]
7. Increased expression of the natural killer cell inhibitory receptor CD94/NKG2A and CD158b on circulating and lesional T cells in patients with chronic plaque psoriasis. Liao YH, Jee SH, Sheu BC, Huang YL, Tseng MP, Hsu SM, Tsai TF. Br J Dermatol; 2006 Aug; 155(2):318-24. PubMed ID: 16882169 [Abstract] [Full Text] [Related]
8. The role of TCR stimulation and TGF-beta in controlling the expression of CD94/NKG2A receptors on CD8 T cells. Gunturi A, Berg RE, Crossley E, Murray S, Forman J. Eur J Immunol; 2005 Mar; 35(3):766-75. PubMed ID: 15714583 [Abstract] [Full Text] [Related]
17. Association of CD94/NKG2A, CD94/NKG2C, and its ligand HLA-E polymorphisms with Behcet's disease. Seo J, Park JS, Nam JH, Bang D, Sohn S, Lee ES, Park KS. Tissue Antigens; 2007 Oct; 70(4):307-13. PubMed ID: 17767552 [Abstract] [Full Text] [Related]
20. [Different responses of CD94/NKG2A-bright and CD94/NKG2A-dim NK cell subsets isolated from patients with multiple sclerosis to interferon-beta]. Li L, Deng YC, Zhao G. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Jun; 23(6):533-5. PubMed ID: 17553351 [Abstract] [Full Text] [Related] Page: [Next] [New Search]